[go: up one dir, main page]

FR2938766B1 - Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries - Google Patents

Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries

Info

Publication number
FR2938766B1
FR2938766B1 FR0806631A FR0806631A FR2938766B1 FR 2938766 B1 FR2938766 B1 FR 2938766B1 FR 0806631 A FR0806631 A FR 0806631A FR 0806631 A FR0806631 A FR 0806631A FR 2938766 B1 FR2938766 B1 FR 2938766B1
Authority
FR
France
Prior art keywords
hydrolysat
aconitase
mitochondria
protector
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0806631A
Other languages
English (en)
Other versions
FR2938766A1 (fr
Inventor
Farra Claude Dal
Nouha Domloge
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ISP Investments LLC
Original Assignee
ISP Investments LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ISP Investments LLC filed Critical ISP Investments LLC
Priority to FR0806631A priority Critical patent/FR2938766B1/fr
Publication of FR2938766A1 publication Critical patent/FR2938766A1/fr
Application granted granted Critical
Publication of FR2938766B1 publication Critical patent/FR2938766B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/78—Enzyme modulators, e.g. Enzyme agonists

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cosmetics (AREA)
FR0806631A 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries Expired - Fee Related FR2938766B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR0806631A FR2938766B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0806631A FR2938766B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries

Publications (2)

Publication Number Publication Date
FR2938766A1 FR2938766A1 (fr) 2010-05-28
FR2938766B1 true FR2938766B1 (fr) 2010-12-31

Family

ID=40791288

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0806631A Expired - Fee Related FR2938766B1 (fr) 2008-11-26 2008-11-26 Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries

Country Status (1)

Country Link
FR (1) FR2938766B1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8980876B2 (en) 2010-10-28 2015-03-17 The Procter & Gamble Company Inhibition of microbial growth by aconitase inhibition
FR2989270B1 (fr) * 2012-04-12 2016-12-30 Soc La Biochimie Appliquee Composition cosmetique cutanee anti-age contenant des activateurs de l'aconitase mitochondriale
WO2020264076A1 (fr) 2019-06-28 2020-12-30 The Procter & Gamble Company Méthode de traitement augmenté par la lumière

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001078674A1 (fr) * 2000-04-18 2001-10-25 Ceteris Holding B.V. -Amsterdam (Olanda)- Succursale Di Lugano Composition a base d'extraits naturels utilisee pour prevenir ou traiter les rides cutanees
FR2808190B1 (fr) * 2000-04-28 2002-06-21 Oreal Extrait de vegetal de l'espece vitis vinifera comme inhibiteur de no-synthase et utilisations
FR2808682B1 (fr) * 2000-05-10 2002-08-16 Michel Fauvel Produit cosmetique a base de cellules vegetales convenant notamment aux soins de la peau
FR2898493B1 (fr) * 2006-03-16 2008-08-08 Af Consulting Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes
FR2915397B1 (fr) * 2007-04-27 2012-01-20 Vincience Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
FR2915377B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu de l'amarante (amaranthus) pour preparer une composition destinee a proteger les mitochondries
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries

Also Published As

Publication number Publication date
FR2938766A1 (fr) 2010-05-28

Similar Documents

Publication Publication Date Title
CY1115825T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν λεβετιρακεταμη και διαδικασια παρασκευης τους
MA28921B1 (fr) Derive heterocyclique azote et medicament le contenant en tant que principe actif
EP1961764A4 (fr) Produit d'addition de chaine de sucres et de peptide et produit pharmaceutique comprenant ce produit en tant que principe actif
BRPI0508540A (pt) composto, composição farmacêutica, e, uso de um composto
IL190951A0 (en) Method of acting upon organism by targeted delivery of biologicaly active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
WO2007062078A3 (fr) Composes modulant l'activite thrombopoietine et procedes correspondants
EP2153831A4 (fr) Agent anti-fatigue et composition orale comprenant chacun de l'andrographolide en tant que principe actif
EP2058317A4 (fr) Dérivé d'ester de l'acide aminophosphorique et modulateur de récepteur s1p contenant le dit dérivé en tant que principe actif
CY1108794T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου
BRPI0910495A2 (pt) "formulação, método de tratamento de plantas, método de aumento da eficácia de uma formulação, herbicida, e, uso de uma mistura"
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
BRPI0813926A2 (pt) Utilização de uma substância, composição e métodos de triagem de princípios ativos que inibem a formação dos ages e de cuidado cosmético.
BRPI0620229A8 (pt) formulação
ATE485261T1 (de) Salicylsäurederivate
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
EP1608395A4 (fr) Agent anticancereux comprenant une proteine lk8 en tant que principe actif
NO20091517L (no) Emulsjon
CR10050A (es) Combinacion fungicida de productos activos
FR2938766B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur de l'aconitase et protecteur des mitochondries
EP2053038A4 (fr) Dérivé d'aminoalcool et immunodépresseur le contenant en tant que principe actif
BRPI1100012A2 (pt) agente para realçar a expressão de fatores associados com redox
FR2938765B1 (fr) Composition cosmetique et/ou pharmaceutique comprenant un hydrolysat de feuille de vigne (vitis vinifera l.) en tant que principe actif activateur des proteines sirt
CY1111361T1 (el) Νεα προσδεματα συναγωνιστες των υποδοχεων rar, χρηση στην ανθρωπινη ιατρικη καθως και στην κοσμετολογια
BRPI0513502A (pt) inseticidas e/ou acaricidas seletivos à base de compostos dicarbonila cìclicos, substituìdos e protetores
WO2006103119A3 (fr) Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation dans des medicaments administrables aux hommes et aussi dans les cosmetiques

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160729